Troy A. Ignelzi - Insider Trading & Ownership

Entity
Individual
Location
C/O Esperion Therapeutics, Inc., 46701 Commerce Center Drive, Plymouth, MI
Summary
The estimated net worth of Troy A. Ignelzi is at least $18.3M dollars as of June 10, 2024. Troy A. Ignelzi is the Chief Financial Officer of Karuna Therapeutics, Inc. and owns shares of Karuna Therapeutics, Inc. stock worth about $18.3M.
All Insider Reports
All Insider Reports

Ownership of Troy A. Ignelzi

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
KRTX Karuna Therapeutics, Inc. Chief Financial Officer $18.3M Aug 22, 2023
CINC CinCor Pharma, Inc. Director Feb 24, 2023
CTNM Contineum Therapeutics, Inc. Director May 24, 2024
RAPP Rapport Therapeutics, Inc. Chief Financial Officer Jun 6, 2024

Insider Transactions Reported by Troy A. Ignelzi:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.